ACOT7 |
protein-coding |
32469171 |
Cell proliferation assay;Migration assay;Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
ACOT7 gene silencing induced a less malignant phenotype and was closely correlated to reduced cell proliferation and migration, altered cell cycle, and increased apoptosis. |
target/prognosis |
0.025 |
- |
- |
ACOT7 |
protein-coding |
32469171 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
NMRAL2P indirectly methylated ACOT7 by binding to DNMT3b, thereby suppressing ACOT7 expression. |
target/prognosis |
0.025 |
- |
- |
ACTN4 |
protein-coding |
28581489 |
Western blot |
cell line |
- |
- |
- |
Up |
- |
No Reports |
Upregulated in GC Cell Lines |
target |
- |
- |
- |
ACTN4 |
protein-coding |
28581489 |
Adhesion assay;Migration assay;Invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Downregulation of Actn4 enhances GC cell adhesion, suppresses migration and invasion of GC Cells |
target |
- |
- |
- |
ADAM10 |
protein-coding |
26852749 |
Cell proliferation assay;Colony formation;Invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM10 overexpression rescued the effect of miR-448-mediated GC cell proliferation, colony formation, and invasion |
- |
- |
- |
- |
ADAM10 |
protein-coding |
26852749 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM10 was a direct target gene of miR-448 in GC cell |
- |
- |
- |
- |
ADAM10 |
protein-coding |
29152656 |
Colony formation assay;MTS assay;Viability assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM10 contributes to proliferation and desensitization of GC cells to cisplatin |
- |
- |
- |
- |
ADAM10 |
protein-coding |
29152656 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR‑320a directly targets ADAM10 in GC cells. |
- |
- |
- |
- |
ADAM17 |
protein-coding |
30569104 |
Cell proliferation assay; Migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM17 promotes the viability and migration of gastric cancer cells. |
prognosis |
- |
- |
0.618 (Mortality risk) |
ADAM9 |
protein-coding |
29879625 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADMA9 was a target of miR-129-5p in GC cells. |
- |
- |
- |
- |
ADAM9 |
protein-coding |
29879625 |
Cell proliferation assay; Invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
|
- |
- |
- |
- |
ADAM9 |
protein-coding |
28260063 |
Cell proliferation assay; Cell cycle analysis. |
cell line |
- |
- |
- |
- |
- |
No Reports |
|
target |
- |
- |
- |
ADAM9 |
protein-coding |
28260063 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM9 is a direct target post-transcriptionally regulated by miR-126 in GC cells. |
target |
- |
- |
- |
ADGRE5 |
protein-coding |
26034356 |
Cell proliferation assay; Invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Exosomes isolated from SGC/wt (high CD97 expression ) cells significantly promoted tumor cell proliferation in a dose-dependent manner in vitro. SGC/wt exosomes also significantly elevated the invasiveness of both SGC/wt and SGC/kd (low CD97 expression) cells as compared to the exosomes released by SGC/kd cells. |
mechanism |
- |
- |
- |
ADRM1 |
protein-coding |
24968865 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of Adrm1 promoted cell proliferation of conditionally-immortalized, mouse ImSt gastric epithelial cells, with increased S1 phase fraction and decreased expression of p21(Cip1). These results collectively indicate that ADRM1 promoted gastric epithelial cell proliferation by cell cycle progression |
target |
- |
- |
- |
AFAP1-AS1 |
lncRNA |
28451917 |
Cell proliferation assay; Colony formation assay; Cell apoptosis assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AFAP1-AS1 knockdown suppressed cell viability of SGC7901 transfected with si-AFAP1-AS1. The number of apoptotic SGC7901 cell transfected with si-AFAP1-AS1 was increased by 3.4-fold comparing to that of control. |
- |
- |
- |
- |
AFAP1-AS1 |
lncRNA |
28975981 |
Cell proliferation assay; Invasion assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of lncRNA AFAP1-AS1 significantly inhibited the cell proliferation and cell cycle progression. Reduced lncRNA AFAP1-AS1 also inhibited the cell invasion ability via regulating cell epithelial-mesenchymal transition (EMT) phenomenon in GC. |
prognosis |
0.001 |
- |
- |
AFAP1L2 |
protein-coding |
24387290 |
Clonogenic assay; Soft agar colony-forming assay; Flow cytometry; BrdU incorporation assay; Cell viability assay; Invasion and migration assay; Xenograft model |
cell line |
- |
- |
- |
- |
- |
No Reports |
The proliferation, migration, and invasion of GC cell lines were all significantly inhibited by knockdown of XB130. In a xenograft model, tumor growth was markedly inhibited after shXB130-transfected GC cells were implanted into nude mice. After XB130 knockdown, GC cells showed a more epithelial-like phenotype. Silencing of XB130 reduced the expression of p-Akt/Akt, upregulated expression of epithelial markers including E-cadherin, aβ-catenin and β-catenin, and downregulated mesenchymal markers including fibronectin and vimentin. |
target |
- |
- |
- |
AGAP2-AS1 |
lncRNA |
28209205 |
Cell proliferation assay; Invasion and migration assay; Cell apoptosis assay; Tumor formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of AGAP2-AS1 significantly inhibited GC cell proliferation, migration, and invasion in vitro and tumor growth in vivo. |
prognosis |
0.002 |
0.025 |
- |
AGAP2-AS1 |
lncRNA |
28209205 |
Luciferase reporter assay; ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SP1 could bind to all of these promoter regions of AGAP2-AS1 |
prognosis |
0.002 |
0.025 |
- |
AGAP2-AS1 |
lncRNA |
28209205 |
RNA immunoprecipitation |
cell line |
- |
- |
- |
- |
- |
No Reports |
AGAP2-AS1 functions as an oncogenic lncRNA by interacting with LSD1 and EZH2 and suppressing CDKN1A (P21) and E-cadherin transcription. |
prognosis |
0.002 |
0.025 |
- |
AGER |
protein-coding |
24441189 |
Cell proliferation assay; Invasion and migration assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of RAGE reduced cell proliferation and invasion of gastric cancer with decreased expression of AKT, PCNA and MMP-2, and induced cell apoptosis and cycle arrest |
target |
- |
- |
- |
AK023391 |
lncRNA |
29282102 |
Cell viability assay; Invasion and migration assay; Colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of AK023391 inhibits the proliferation, colony formation, DNA synthesis, migration, invasion of GC cells, and induces apoptosis and cell cycle arrest. |
prognosis |
0.0024 |
- |
0.56 |
AK023391 |
lncRNA |
29282102 |
IHC; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
LncRNA AK023391 is involved in the regulation of the PI3K/Akt signaling pathway |
prognosis |
0.0024 |
- |
0.56 |
AKAP12 |
protein-coding |
15258566 |
MSP |
cell line |
- |
- |
- |
- |
- |
No Reports |
Two isoforms AKAP12A and AKAP12B are independently expressed and were absent from the majority of human gastric cancer cells. 5' CpG islands of both AKAP12A and AKAP12B are frequently hypermethylated in GC cells. DNA methylation is directly involved in the transcriptional silencing of AKAP12 in gastric cancer cells. |
mechanism |
- |
- |
- |
AKAP12 |
protein-coding |
15258566 |
Cell proliferation assay; Colony formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
The restoration of AKAP12A in AKAP12-nonexpressing cells reduced colony formation and induced apoptotic cell death |
mechanism |
- |
- |
- |
AKT2 |
protein-coding |
28404925 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Suppression of AKT2 significantly inhibited gasric cancer cell proliferation, induced cell apoptosis and inhibited the migration and invasion of GC cells. |
- |
- |
- |
- |
AKT3 |
protein-coding |
29228422 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AKT3 was chosen as the target gene of miR-582-5p. Moreover, restoration of AKT3 could impair tumor suppression role of miR-582-5p on gastric cancer growth. |
target |
- |
- |
- |
ANGPTL6 |
protein-coding |
31146977 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
ANGPTL6 was overexpressed in Alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC) cell lins compared to that of common gastric cell lines; A high level of ANGPTL6 confers a poor prognosis and is correlated with the expression of CD34 (an endothelial cell marker). |
target |
- |
- |
- |
ANGPTL6 |
protein-coding |
31146977 |
HUVEC tube formation assay; HUVEC proliferation assay; Invasion and migration assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
ANGPTL6 promotes endothelial cell migration and tube formation, Moreover, ANGPTL6 knockdown inhibits cancer cell apoptosis and invasiveness. Mechanistically, ANGPTL6 activates the ERK1/2 and AKT pathways. Treatment of ERK1/2 or AKT inhibitor can attenuated cell migration and tube formation. |
target |
- |
- |
- |
ANKRD40CL |
protein-coding |
32293550 |
Cell viability assay; Invasion and migration assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of LINC00483 inhibited cells viability, migration and invasion but promoted apoptosis in gastric cancer cells. |
target |
- |
- |
- |
ANKRD40CL |
protein-coding |
32293550 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
LINC00483 could increase MAPK1 expression by competitively sponging miR-490-3p. miR-490-3p overexpression suppressed gastric cancer development, which was abated by introduction of LINC00483 |
target |
- |
- |
- |
ANXA4 |
protein-coding |
30837034 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-203 Directly Targets Annexin A4 in GC Cells |
- |
- |
- |
- |
ARHGAP5 |
protein-coding |
30250020 |
Cell invasion and migration assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
ARHGAP5 is involved in SIRT1-induced suppression of GC cell migration and invasion in vitro. |
prognosis |
0.002 |
- |
- |
ARID1A |
protein-coding |
22808142 |
Cell proliferation assay; Colony Formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Silencing the expression of ARID1A in GES1 significantly enhanced cell proliferation compared with mock siRNA treatment |
prognosis |
0.003 |
- |
- |
ASCL2 |
protein-coding |
29746925 |
qRT-PCR; FACS; Tumorsphere formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ASCL2+ cells showed increased propensity of growing as tumorspheres |
target/prognosis |
< 0.001 |
- |
- |
ASCL2 |
protein-coding |
29746925 |
ChIP-qPCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
SMYD3 maintains high H3K4me3 levels on the ASCL2 promoter in ASCL2+ cells, indicating its potential role in regulating ASCL2 transcription and expression. |
target/prognosis |
< 0.001 |
- |
- |
ASCL2 |
protein-coding |
29746925 |
qRT-PCR; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
Depletion of SMYD3 inhibits Wnt-induced upregulation of ASCL2. |
target/prognosis |
< 0.001 |
- |
- |
ASCL2 |
protein-coding |
30106147 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
ASCL2 expression contributes to cell migration and invasion in GC cells. |
target |
- |
- |
- |
ASCL2 |
protein-coding |
30106147 |
Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
the expression of E-cadherin in ASCL2-overexpressing cell lines decreased, while Zeb-1, twist-related protein 1 (Twist), Integrin, Vimentin, 72 kDa type IV collagenase (MMP-2) and matrix metalloproteinase 9 (MMP-9) were upregulated in ASCL2-overexpressing cell lines |
target |
- |
- |
- |
ASCL2 |
protein-coding |
30106147 |
Luciferase reporter assay; ChIP |
cell line |
- |
- |
- |
- |
- |
No Reports |
ASCL2 may interact with the promoter of pre-miR223, and inhibit the maturation of miR223. |
target |
- |
- |
- |
ATF7 |
protein-coding |
29754469 |
Cell proliferation assay; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
siATF7 increased the accumulation of cells at the G2/M phase; ATF7 rescues the cellular phenotypes induced by miR-103a-3p in gastric cancer cells. |
- |
- |
- |
- |
ATF7 |
protein-coding |
29754469 |
Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
both miR-103a-3p overexpression and ATF7 silencing promoted the expression of CDK2 |
- |
- |
- |
- |
ATF7 |
protein-coding |
29754469 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-103a-3p directly regulates ATF7 expression in GC cells. |
- |
- |
- |
- |
ATP6V1A |
protein-coding |
28592880 |
ChIP-qPCR; qRT-PCR; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
YY1 transcriptionally regulates ATP6V1A, and the ATP6V1A core promoter region contains three YY1 binding sites. RNAi-mediated knockdown of YY1 in GC cells significantly decreased ATP6V1A mRNA and protein expression, while YY1 overexpression increased ATP6V1A expression level |
prognosis |
0.01 |
- |
- |
BAG3 |
protein-coding |
30514177 |
qRT-PCR; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
BAG3 mRNA and protein levels were increased following treatment with HGF. HGF-mediated BAG3 upregulation increased cell proliferation and cell invasion; however, it decreased apoptosis. HGF-mediated BAG3 upregulation is regulated by an ERK and Egr1-dependent pathway. BAG3 may have an important role in HGF-mediated cell proliferation and metastasis in gastric cancer through an ERK and Egr1-dependent pathway. |
target |
- |
- |
- |
BAG3 |
protein-coding |
30514177 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
HGF-mediated BAG3 upregulation increased cell proliferation and cell invasion; however, it decreased apoptosis. |
target |
- |
- |
- |
BCL2L2 |
protein-coding |
16707418 |
Gelatin zymography; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
Bcl-w overexpression increased matrix metalloproteinase-2 (MMP-2) expression, and synthetic or natural inhibitors of MMP-2 abolished Bcl-w induced cell invasion. Bcl-w overexpression also activated phosphoinositide 3-kinase (PI3K), Akt, and Sp1. |
mechanism |
- |
- |
- |
BMI1 |
protein-coding |
30156609 |
qRT-PCR; Cell transfection |
cell line |
- |
- |
- |
- |
- |
No Reports |
expression of BMI1 affected the expression of apoptosis_x005frelated proteins and thus inhibited the activation of the apoptotic pathway. Overexpression of BMI1 could activate the Notch and mTOR signaling pathways |
- |
- |
- |
- |
BMI1 |
protein-coding |
26894855 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Bmi-1 is a direct target of miR-15a in gastric cancer cell lines. |
prognosis |
0.024 |
- |
- |
BNC2-AS1 |
lncRNA |
30549996 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony forming assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
BNC2-AS1-knockdown significantly suppressed gastric cancer cell proliferation, migration and suppressed gastric cancer cell invasion |
- |
- |
- |
- |
BRD4 |
protein-coding |
29434197 |
Cell proliferation assay; Invasion and migration assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
The BET inhibitor JQ1 inhibits gastric cancer cell proliferation by inducing cellular senescence. BRD4 is involved in JQ1-induced cellular senescence. |
target |
- |
- |
- |
BRD4 |
protein-coding |
29434197 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BRD4 regulates the 3′-UTR of p21. mRNA CDKN1A |
target |
- |
- |
- |
BRD4 |
protein-coding |
29434197 |
CHIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BRD4, together with E2F1, regulates miR-106b-5p transcription and cellular senescence. |
target |
- |
- |
- |
BTG1 |
protein-coding |
26050197 |
RT-PCR; Western blot; MS-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG1 protein expression (19 kDa) was detectable in gastric cancer and epithelial cell lines; BTG1 mRNA was high expressed in cancer and epithelial cells and a decreased level of methylation of BTG1 after treated with 5-Aza-dC. |
target/prognosis |
0.047 |
- |
- |
BTG1 |
protein-coding |
26050197 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG1 overexpression suppressed tumor growth and lung metastasis of gastric cancer cells. |
target/prognosis |
0.047 |
- |
- |
BTG2 |
protein-coding |
27409164 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry; Apotosis assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of BTG2 triggered G1/S cell cycle arrest, induced subsequent apoptosis, and inhibited C-myc activation following Ras/MEK/ERK signaling pathway, which involved in the biological effects of miR-27a-3p/BTG2 axis on gastric carcinogenesis and cancer progression. |
- |
- |
- |
- |
BTG2 |
protein-coding |
27409164 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG2 was a direct and functional target of miR-27a-3p in gastric cancer and miR-27a-3p inhibition obviously up-regulated the expression of BTG2. |
- |
- |
- |
- |
BTG3 |
protein-coding |
25904053 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG3 overexpression inhibited proliferation, induced S/G2 arrest, differentiation, autophagy, apoptosis, suppressed migration and invasion |
target |
- |
- |
- |
BTG3 |
protein-coding |
25904053 |
qRT-PCR; Cell transfection |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG3 transfectants showed a higher mRNA expression of p27, Bax, 14-3-3, Caspase-3, Caspase-9, Beclin 1, NF-κB, IL-1, -2, -4, -10 and -17, but a lower mRNA expression of p21, MMP-9 and VEGF than the control and mock;exposed to cisplatin (DDP), MG132, paclitaxel, and SAHA, BTG3 transfectants showed a lower viability and a higher apoptotic level than the control in both concentration and time-dependent manners |
target |
- |
- |
- |
BTG3 |
protein-coding |
25238703 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG3 suppressed the proliferation of GC cells in vitro. It also inhibited migration and invasion of GC cells in vitro. |
target/prognosis |
0.001 |
- |
- |
BTG4 |
protein-coding |
19576178 |
Bisulfite sequencing |
cell line |
- |
- |
- |
- |
- |
No Reports |
Most CpG dinucleotides were methylated in gastric cancer cell lines, the methylation was absent in GES-1 cells |
mechanism |
- |
- |
- |
BTG4 |
protein-coding |
19576178 |
Flow cytometry; Cell growth assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG4 reexpression sensitizes gastric cancer cells to proapoptotic stimuli and reduces colony formation in vitro. |
mechanism |
- |
- |
- |
C1QTNF6 |
protein-coding |
30431096 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Interference of C1QTNF6 expression influenced the proliferation, migration and invasion ability of Gc cells in vitro. |
target |
- |
- |
- |
C8orf76 |
protein-coding |
30733230 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
C8orf76 promotes cell growth and cell-cycle progression, but inhibits cell apoptosis |
prognosis |
< 0.0001 |
- |
- |
C8orf76 |
protein-coding |
30733230 |
Luciferase reporter assay; Western blot; qRT-PCR; ChIP-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
DUSP5P1 is a direct downstream target of C8orf76 |
prognosis |
< 0.0001 |
- |
- |
CA11 |
protein-coding |
11562744 |
Cell coloney formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CA11 transfected MKN28 cells also displayed a marked decrease in the number of colony formations when compared to double normal controls. |
- |
- |
- |
- |
CASC15 |
lncRNA |
29272000 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of LncRNA CASC15 promoted the proliferation of MKN28 cells. |
prognosis |
0.013 |
- |
- |
CBFB |
protein-coding |
29386218 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CBFB is a miR-204-5p target gene and promotes gastric cancer cell growth |
prognosis |
< 0.001 |
- |
- |
CBFB |
protein-coding |
29386218 |
Cell proliferation assay; Cell colony formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
CBFB promotes gastric cancer cell growth |
prognosis |
< 0.001 |
- |
- |
CCAT1 |
lncRNA |
28535628 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Down-regulation of CCAT1 in MGC-803 and SGC-7901 cells significantly inhibited the cell proliferation. |
target |
- |
- |
- |
CCAT2 |
lncRNA |
28248065 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Silencing of lncRNA CCAT2 inhibits gastric cancer cell proliferation and invasion. |
prognosis |
< 0.05 |
- |
- |
CCEPR |
lncRNA |
29771412 |
Cell proliferation assay; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Down-regulated lncRNA CCHE1 decreased proliferative activity and colony formation capacity.Cell cycle was promot_x005fed in lncRNA CCHE1 up-regulation group. |
target |
- |
- |
- |
CCKBR |
protein-coding |
27518872 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cholecystokinin B receptor (CCK-BR) was a direct target of miR-148a. |
target |
- |
- |
- |
CCKBR |
protein-coding |
27518872 |
Cell proliferation assay; Cell migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
siRNA-induced knockdown of CCK-BR elicited similar anti-oncogenic effects (decreased proliferation and migration) as those induced by enforced miR-148a expression. |
target |
- |
- |
- |
CCN1 |
protein-coding |
30178386 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CYR61 is a novel target of miR‑142‑5p in GC cells |
prognosis |
< 0.001 |
- |
- |
CCN1 |
protein-coding |
27105510 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
knockdown of CYR61 in gastric cancer AGS cells impairs the cancer cell migration and invasion, suggesting a driver role of CYR61 in metastasis |
prognosis |
< 0.001 |
- |
- |
CCND1 |
protein-coding |
29848678 |
Cell proliferation assay; Cell colony formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
ETS1 or CCND1 knockdown significantly suppressed gastric cancer cell growth, similar to miR-193a-3p overexpression. |
mechanism |
- |
- |
- |
CCND1 |
protein-coding |
29848678 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ETS1 and CCND1 are direct targets of miR-193a-3p |
mechanism |
- |
- |
- |
CCND1 |
protein-coding |
27071318 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Regulate cell growth of GC cells. |
- |
- |
- |
- |
CCND1 |
protein-coding |
26955820 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
The enforced expression of si-CCND1 notably repressed cells proliferation, elicited cell cycle arrest at the G0– G1 stage and enhanced apoptosis in both cell lines. |
- |
- |
- |
- |
CCND1 |
protein-coding |
26955820 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cyclin D1 is a direct target of miR-155 in GC cells |
- |
- |
- |
- |
CCND1 |
protein-coding |
23383271 |
Cell proliferation assay; Invasion and migration assays; Flow Cytometry; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of cyclin D1 and Ets1 phenocopied miR-9 over-expression-mediated inhibition on the proliferation, migration and invasion of gastric cancer cells in vitro. |
mechanism |
- |
- |
- |
CCND1 |
protein-coding |
23383271 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-9 directly targeted the 3'-UTR of cyclin D1 and Ets1 |
mechanism |
- |
- |
- |
CD151 |
protein-coding |
23533596 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Down-regulation of CD151 by vshRNA-CD151 impaired metastasis and invasion of HGC-27 cells, but did not affect cell proliferation. CD151-cDNA transfection rescued the metastatic potential and invasiveness of HGC-27-vshCD151 cells, but not those of HGC-27-vshintegrin a3 cells in vitro. |
target/prognosis |
0.007 |
- |
- |
CD151 |
protein-coding |
23533596 |
Co-ip assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
CD151 formed a complex with integrin a3 in HGC cells. |
target/prognosis |
0.007 |
- |
- |
CD276 |
protein-coding |
25120098 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
B7-H3 knockdown by RNA interference decreased cell migration and Transwell invasion up to 50% in vitro. |
target |
- |
- |
- |
CDC42 |
protein-coding |
25152372 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDC42 is the direct target of miR-133a |
mechanism |
- |
- |
- |
CDC42 |
protein-coding |
26549550 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of CDC42 significantly inhibited the proliferation of AGS and SGC7901 cells, and it was suggested that this inhibitory process may be due to cell cycle arrest at G1/S phase and downregulation of cyclin A, cyclin D1, cyclin E and proliferating cell nuclear antigen. Furthermore, knockdown of CDC42 markedly inhibited the migration and invasion of GC cells, and suppressed the expression of matrix metalloproteinase 9 |
target |
- |
- |
- |
CDH1 |
protein-coding |
30063010 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDH1 is a direct target of miR-217 |
mechanism |
- |
- |
- |
CDK6 |
protein-coding |
30530570 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
EGFR and CDK6 are directly targets of miR-1296-5p |
- |
- |
- |
- |
CDK9 |
protein-coding |
28701053 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDK9 is a direct target of miR-613 in gastric cancer |
target |
- |
- |
- |
CDKL1 |
protein-coding |
22369697 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony forming assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Loss of CDKL1 function in both SGC7901 and MGC-803 gastric cancer cells significantly decreases cellular proliferation and increases apoptosis (p < 0.01). |
target |
- |
- |
- |
CDKN1A |
protein-coding |
29434197 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BRD4 regulates the 3′-UTR of p21. mRNA CDKN1A |
- |
- |
- |
- |
CDKN2B-AS1 |
lncRNA |
31242038 |
Apoptosis assay; Migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ANRIL suppresses apoptosis in gastric cancer cell, enhances metastasis |
target/prognosis |
< 0.001 |
- |
- |
CDKN2B-AS1 |
lncRNA |
31242038 |
Xenograft tumor mouse model |
cell line |
- |
- |
- |
- |
- |
No Reports |
ANRIL promotes tumor growth in vivo |
target/prognosis |
< 0.001 |
- |
- |
CDKN2B-AS1 |
lncRNA |
30156609 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of ANRIL suppressed cell viability, migration, and invasion, and increased apoptosis through up-regulating miR-99a. |
target |
- |
- |
- |
CDKN2B-AS1 |
lncRNA |
30156609 |
qRT-PCR; Cell transfection |
cell line |
- |
- |
- |
- |
- |
No Reports |
ANRIL silence_x005finduced up-regulation of miR-99a was significantly reversed by miR-99a inhibitor.ANRIL knockdown down-regulated the expression of BMI1 by modulating miR-99a in gastric cancer cells in vitro |
target |
- |
- |
- |
CEBPA |
protein-coding |
20386538 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
We observed a significant decrease in proliferation in C/EBPa-transfected cells. |
mechanism |
- |
- |
- |
CELF2 |
protein-coding |
29501762 |
Cell proliferation assay; Flow cytometry; Cell migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpressed CELF2 induced cell apoptosis and reduced proliferation ability. |
prognosis |
< 0.01 |
- |
- |
CEMIP |
protein-coding |
28422983 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown KIAA1199 suppressed the proliferation, migration and invasion in GC cells. KIAA1199 stimulated the Wnt/β-catenin signaling pathway and the enzymatic activity of matrix metalloproteinase (MMP) family members and thus accelerated the epithelial-to-mesenchymal transition (EMT) progression in GC cells. |
target/prognosis |
< 0.001 |
- |
- |
CHD5 |
protein-coding |
19840376 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
CHD5 expression was down-regulated in all of gastric cancer cell lines used (100%, 7/7). |
mechanism |
- |
- |
- |
CHD5 |
protein-coding |
19840376 |
MS-PCR; BGS |
tissue/cell line |
- |
- |
- |
- |
- |
No Reports |
Methylation of CHD5 promoter was detected in all of seven gastric cancer cell lines and in the majority of primary gastric carcinoma tissues examined (73%, 11/15). |
mechanism |
- |
- |
- |
CHD5 |
protein-coding |
19840376 |
Colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ectopic expression of CHD5 in gastric cancer cells led to a significant growth inhibition. |
mechanism |
- |
- |
- |
CIAPIN1 |
protein-coding |
19471113 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expression of CIAPIN1 by cDNA transfection resulted in suppression of cell proliferation and inhibition of cell cycle progression while knockdown of CIAPIN1 with siRNA accelerated cell proliferation and promoted cell cycle progression in SGC7901 and MKN28 gastric cancer cells. |
mechanism |
- |
- |
- |
CKS2 |
protein-coding |
21617860 |
Cell proliferation assay; Cell invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
The inhibition of cellular proliferation by CKS2-siRNA was observed in a gastric cancer cell line. |
prognosis |
- |
- |
- |
CLCN3 |
protein-coding |
30217218 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of CLC-3 inhibited cell proliferation and migration in vitro. |
target/prognosis |
0.012 |
- |
- |
CLCN3 |
protein-coding |
30217218 |
Luciferase reporter assay;ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
XRCC5 was identified as a CLC-3 promoter-binding protein, and both CLC-3 and XRCC5 were prognostic factors of overall survival in GC patients. |
target/prognosis |
0.012 |
- |
- |
CLDN18 |
protein-coding |
24647998 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-1303 could bind to the putative binding sites in CLDN18 mRNA 3'-UTR and visibly lower the expression of claudin-18. The introduction of claudin-18 without 3'-UTR restored the miR-1303 promoting migration function. |
target |
- |
- |
- |
CLEC4M |
protein-coding |
28403883 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
DC-SIGNR knockdown inhibited the proliferation, migration and invasion of gastric cancer cells in vitro and DC-SIGNR overexpression promoted cell proliferation, migration and invasion. |
target |
- |
- |
- |
CMTM3 |
protein-coding |
24131472 |
Cell invasion and migration assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Restoration of CMTM3 significantly affected migration and invasion of AGS and SGC-7901 cells |
prognosis |
0.041 |
- |
- |
COL10A1 |
protein-coding |
30154451 |
Cell invasion and migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
COL10A1 regulated the migration and invasion of GC cells. |
prognosis |
0.003/0.000 |
- |
- |
COL10A1 |
protein-coding |
30154451 |
Luciferase reporter assay; ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SOX9 directly binds to the COL10A1 promoter and activates its transcription. |
prognosis |
0.003/0.000 |
- |
- |
COPS7A |
protein-coding |
31409899 |
RNA pull-down assay; RIP; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
KRT19P3 could bind COPS7A directly and might regulate COPS7A activity in GC |
target |
- |
- |
- |
CORO1C |
protein-coding |
22974233 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Coronin 3 is expressed in the cytoplasm of gastric cancer cells. Coronin 3 promoted the migratory, invasive, and in vivo metastatic abilities of gastric cancer cells. |
mechanism |
- |
- |
- |
CPXM2 |
protein-coding |
31364750 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CPXM2 promotes the proliferation and migration of cultured GC cells.CPXM2 may promote GC progression by modulating EMT |
prognosis |
0.007 |
- |
- |
CRK |
protein-coding |
25027343 |
Cell proliferation assay; Cell invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-126 inhibited GC cells invasion but did not affect its proliferation in vitro. |
target |
- |
- |
- |
CRMP1 |
protein-coding |
27864146 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
downregulation of CRMP1 increased cell proliferation and migration, and inhibited apoptosis in GC cells. Additionally, the inhibitory effect of the miR-187 inhibitor on cell migration was reversed by the downregulation of CRMP1. |
target |
- |
- |
- |
CRMP1 |
protein-coding |
27864146 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CRMP1 was a direct downstream target of miR-187 in GC.The effects of miR-187 inhibitor on cell migration and cell apoptosis were reversed by CRMP1 downregulation |
target |
- |
- |
- |
CRNDE |
lncRNA |
28490034 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of CRNDE increased GC cell viability and promoted colony formation. Knockdown of CRNDE did not result in loss of expression-related effects on cell proliferation and colony formation. |
target |
- |
- |
- |
CRNDE |
lncRNA |
28490034 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-145 target gene E2F3 was strongly expressed following CRNDE competitive molecular sponging of miR-145. |
target |
- |
- |
- |
CRNDE |
lncRNA |
29243780 |
Cell proliferation assay; Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of CRNDE inhibited cell proliferation, migration and invasion of GC. |
prognosis |
0.0066 |
- |
- |
CRNDE |
lncRNA |
29243780 |
Western blot; cell transfection |
cell line |
- |
- |
- |
- |
- |
No Reports |
CRNDE exerted its oncogenic role by affecting PI3K/AKT signaling pathways. |
prognosis |
0.0066 |
- |
- |
CTBP1 |
protein-coding |
27983935 |
Cell proliferation assay; Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Suppression of CtBP1 Inhibits Proliferation, Invasion, and EMT Progression in GC Cells |
mechanism |
- |
- |
- |
CTBP1 |
protein-coding |
27983935 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CtBP1 is a putative target gene of miR-644a in GC cells |
mechanism |
- |
- |
- |
CTHRC1 |
protein-coding |
25510669 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cthrc1 was a direct target of let-7b. |
mechanism |
- |
- |
- |
DDX5 |
protein-coding |
30029874 |
RIP and Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-5590-3p as a direct target of DDX5 |
mechanism |
- |
- |
- |
DNMT3A |
protein-coding |
26350239 |
Cell proliferation assay; Flow Cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
DNMT3A promotes tumor cell proliferation and cell growth by disrupting the G1/S checkpoint. |
target |
- |
- |
- |
DNMT3A |
protein-coding |
26350239 |
ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
DNMT3A modulated p18INK4C by directly binding to and silencing the p18INK4C gene via promoter hypermethylation. |
target |
- |
- |
- |
DUSP5P1 |
lncRNA |
30733230 |
Luciferase reporter assay; Western blot; qRT-PCR; ChIP-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
DUSP5P1 is a direct downstream target of C8orf76 |
mechanism |
- |
- |
- |
DUSP5P1 |
lncRNA |
30733230 |
Cell proliferation assay; Cell colony formation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
DUSP5P1 promotes gastric cancer cell growth in vitro. |
mechanism |
- |
- |
- |
EGFR |
protein-coding |
30530570 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
EGFR and CDK6 are directly targets of miR-1296-5p |
mechanism |
- |
- |
- |
ELAVL1 |
protein-coding |
26819420 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Over-expression of HuR resulted in the increase in the cell activity of gastric cancer (P<0.001). Suppression of HuR decreased the cell activity of gastric cancer (P=0.001). |
mechanism |
- |
- |
- |
ELAVL1 |
protein-coding |
26819420 |
Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
The protein level of HuR in the gastric cancer cells was higher than that in the control cells. |
mechanism |
- |
- |
- |
EPHA8 |
protein-coding |
31026069 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of Epha8 reduces cell proliferation; EphA8 promotes GC cell migration and invasion |
prognosis |
< 0.001 |
- |
- |
EPHA8 |
protein-coding |
31026069 |
Western blot; Coimmuno precipitation experiments;Immunofluorescence microscopy |
cell line |
- |
- |
- |
- |
- |
No Reports |
EphA8 interacts with ADAM10 to affect GC cell growth |
prognosis |
< 0.001 |
- |
- |
ERBB4 |
protein-coding |
29620274 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Silencing of ERBB4 expression suppresses GC cell proliferation. |
target |
- |
- |
- |
ETS1 |
protein-coding |
29848678 |
Cell proliferation assay; Cell colony formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
ETS1 or CCND1 knockdown significantly suppressed gastric cancer cell growth, similar to miR-193a-3p overexpression. |
mechanism |
- |
- |
- |
ETS1 |
protein-coding |
29848678 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ETS1 and CCND1 are direct targets of miR-193a-3p |
mechanism |
- |
- |
- |
ETS1 |
protein-coding |
23383271 |
Cell proliferation assay; Invasion and migration assays; Flow Cytometry; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of cyclin D1 and Ets1 phenocopied miR-9 over-expression-mediated inhibition on the proliferation, migration and invasion of gastric cancer cells in vitro. |
mechanism |
- |
- |
- |
ETS1 |
protein-coding |
23383271 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-9 directly targeted the 3'-UTR of cyclin D1 and Ets1 |
mechanism |
- |
- |
- |
EZH2 |
protein-coding |
30952377 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
knockdown of EZH2 expression by siRNA could impair cell proliferation and invasion both in vitro. |
prognosis |
0.001 |
- |
- |
EZH2 |
protein-coding |
30952377 |
Xenograft mice models |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of EZH2 inhibits gastric cancer cells tumorigenesis in vivo. |
prognosis |
0.001 |
- |
- |
EZH2 |
protein-coding |
30952377 |
CHIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
EZH2 could directly bind to P21 promoter region and mediate H3K27me3 modification. |
prognosis |
0.001 |
- |
- |
FADD |
protein-coding |
28848149 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
FADD is a potential target of miR-675; H19/miR-675 axis inhibited expression of FADD. FADD downregulation subsequently inhibited the caspase cleavage cascades including caspase 8 and caspase 3. |
target |
- |
- |
- |
FADD |
protein-coding |
28848149 |
Cell proliferation assay; Colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
FADD mediates the pro-proliferation and anti-apoptosis function of miR-675 |
target |
- |
- |
- |
FLJ22763 |
lncRNA |
30716442 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
LncRNA FLJ22763 inhibits cells proliferation, migration, and invasion |
target/prognosis |
0.003 |
- |
- |
FLJ22763 |
lncRNA |
30716442 |
qRT-PCR; Cell tranfection; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
FLJ22763 was negatively associated with ACLY, regulating the mRNA and protein levels of ACLY |
target/prognosis |
0.003 |
- |
- |
FOXM1 |
protein-coding |
27086911 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
FoxM1 is a direct target of miR-320a |
mechanism |
- |
- |
- |
FZD7 |
protein-coding |
29559846 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of FZD7 suppressed gastric cancer cell growth, migration and invasion |
target/prognosis |
< 0.001 |
< 0.001 |
- |
GAS5 |
lncRNA |
25959498 |
Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
lncRNA GAS5 knock-down abolishes cell cycle arrest at the G1 phase |
target |
- |
- |
- |
GAS5 |
lncRNA |
25959498 |
RNA pull-down assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
lncRNA GAS5 interacts with the transcriptional activator YBX1. |
target |
- |
- |
- |
GNAQ |
protein-coding |
28350126 |
Cell proliferation assay; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Silencing of GNAQ markedly suppressed proliferation and colony formation in GC cells, and arrested the cell cycle at the S phase. |
target |
- |
- |
- |
GNAQ |
protein-coding |
28350126 |
Western blot; cell transfection |
cell line |
- |
- |
- |
- |
- |
No Reports |
GNAQ directly or indirectly inhibits p53 and several key regulators of cell cycle signaling. GNAQ expression was required for MEK/ERK phosphorylation in MGC80-3 cells. |
target |
- |
- |
- |
H19 |
lncRNA |
28848149 |
Cell proliferation assay; Colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of H19 and miR-675 promoted cell proliferation and inhibited cell apoptosis, whereas knockdown of H19 and miR-675 inhibited these effects. |
mechanism |
- |
- |
- |
HOTAIR |
lncRNA |
30810117 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
HOTAIR knockdown had anti-tumor effects that suppressed gastric cancer cell proliferation by increasing cell apoptosis and keeping the cell cycle in G1 phase. |
mechanism |
- |
- |
- |
HOXA1 |
protein-coding |
26791264 |
Cell proliferation assay; Invasion and migration assays; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of HOXA1 in GC cells inhibited cell proliferation, migration, and invasion in vitro; Knockdown of HOXA1 expression induces changes in the cell cycle of GC cells and decreases cyclin D1 expression |
prognosis |
< 0.001 |
< 0.001 |
- |
hsa_circ_0000199 |
circRNA |
30927924 |
Cell cytotoxicity assay; Clonogenic assay; Flow ytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
circAKT3 promotes DNA damage repair and inhibits the apoptosis of GC cells in vitro. Downregulation of circAKT3 facilitates cisplatin sensitivity of CDDP-resistant GC cells in vitro. |
target/prognosis |
- |
0.0293 |
0.91 |
hsa_circ_0000199 |
circRNA |
30927924 |
Luciferase reporter assay: RNA pull-down; FISH |
cell line |
- |
- |
- |
- |
- |
No Reports |
circAKT3 and miR-198 were colocalized in the cytoplasm; circAKT3 exerts its function by sponging miR-198. |
target/prognosis |
- |
0.0293 |
0.91 |
hsa_circ_0000993 |
circRNA |
30215537 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
hsa_circ_0000993 has a lower expression level in highly aggressive cell line BGC-823 as compared with poorly aggressive cell line SGC-7901 |
target |
- |
- |
- |
hsa_circ_0000993 |
circRNA |
30215537 |
FISH |
cell line |
- |
- |
- |
- |
- |
No Reports |
FISH showed that hsa circ 0000993 was expressed both in nucleus and cytoplasm and mainly in nucleus of gastric cancer cells. |
target |
- |
- |
- |
hsa_circ_0000993 |
circRNA |
30215537 |
Cell proliferation assay; Invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Increased expression of hsa circ 0000993 was associated with decreased migration, invasion and proliferation of gastric cancer cells. |
target |
- |
- |
- |
hsa_circ_0000993 |
circRNA |
30215537 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
hsa_circ_0000993 acts as a miRNA sponge for miR-214-5p |
target |
- |
- |
- |
hsa_circ_0004771 |
circRNA |
30717751 |
Pull-down assay; Luciferase reporter |
cell line |
- |
- |
- |
- |
- |
No Reports |
circNRIP1 serves as a miRNA sponge of miR-149-5p |
prognosis |
0.0019 |
0.004 |
- |
hsa_circ_0004771 |
circRNA |
30717751 |
Cell proliferation assay; Invasion and migration assay; Clonogenic assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of circNRIP1 inhibits the proliferation, migration, invasion and expression level of AKT1 in GC cells in vitro |
prognosis |
0.0019 |
0.004 |
- |
hsa_circ_0092303 |
circRNA |
31182928 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
CircCACTIN promotes proliferation, invasion, and migration of GC cells in vitro. |
target |
- |
- |
- |
hsa_circ_0092303 |
circRNA |
31182928 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Binding interaction exists between circCACTIN and miR-331-3p. |
target |
- |
- |
- |
HSPB8 |
protein-coding |
29693129 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of HSPB8 inhibits gastric cancer cell proliferation, promotes gastric cancer cell apoptosis |
- |
- |
- |
- |
ITGA3 |
protein-coding |
23533596 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
silencing of integrin a3 markedly inhibited the invasion of HGC27 cells. |
target/prognosis |
< 0.0001 |
- |
- |
ITGA3 |
protein-coding |
23533596 |
Co-ip assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
CD151 formed a complex with integrin a3 in HGC cells. |
target/prognosis |
< 0.0001 |
- |
- |
JAZF1 |
protein-coding |
31357957 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
JAZF1 is a direct target of miR-1275 in GC cells. |
prognosis |
<0.001 |
- |
- |
KDM4B |
protein-coding |
24077348 |
Phase-contrast microscopy |
cell line |
- |
- |
- |
- |
- |
No Reports |
JMJD2B inhibition induces the epithelial morphology of gastric cancer cells |
target |
- |
- |
- |
KDM4B |
protein-coding |
24077348 |
qRT-PCR; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
JMJD2B repression results in downregulation of mesenchymal markers and upregulation of epithelial markers |
target |
- |
- |
- |
KDM4B |
protein-coding |
24077348 |
Luciferase reporter activity assay; ChIP assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
JMJD2B is physically associated with b-catenin to regulate vimentin promoter. |
target |
- |
- |
- |
KDM4B |
protein-coding |
24077348 |
Cell invasion and migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
JMJD2B inhibition results in diminished invasion and metastasis in vitro |
target |
- |
- |
- |
KRT19P3 |
lncRNA |
31409899 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
KRT19P3 inhibited GC cell proliferation and induced apoptosis, suppressed GC cell migration and invasion in vitro. |
target/prognosis |
0.0016 |
0.0028 |
- |
KRT19P3 |
lncRNA |
31409899 |
RNA pull-down assay; RIP; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
KRT19P3 could bind COPS7A directly and might regulate COPS7A activity in GC |
target/prognosis |
0.0016 |
0.0028 |
- |
LINC01089 |
lncRNA |
29717028 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
AK096174 knockdown inhibited the proliferation, migration, and invasiveness in SGC-7901 and BGC-823 cells, whereas AK096174 overexpression had the promoting effects. |
target |
- |
- |
- |
LINC01234 |
lncRNA |
29386218 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
promote cell proliferation and cell tomorigenesis, suppress apotosis and G1 arrest |
prognosis |
<0.001 |
<0.001 |
- |
LINC01234 |
lncRNA |
29386218 |
Immunoprecipitation assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
LINC01234 binds directly to Ago2 |
prognosis |
<0.001 |
<0.001 |
- |
LINC01234 |
lncRNA |
29386218 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-204-5p directly target LINC01234 |
prognosis |
<0.001 |
<0.001 |
- |
LINC02859 |
lncRNA |
31207155 |
Cell proliferation assay; Invasion and migration assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
LOC101928316 overexpression can significantly inhibit GC cell migration, invasion, and proliferation. |
target |
- |
- |
- |
LINC02859 |
lncRNA |
31207155 |
Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
lenti-LOC101928316-Overexpression stable infected can remarkably inhibit the expression level of PI3K, p-AKT, mTOR, and p-mTOR in GC cells |
target |
- |
- |
- |
MAPK1 |
protein-coding |
32293550 |
Cell viability assay; Invasion and migration assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of MAPK1 inhibited cells viability, migration and invasion but promoted apoptosis in gastric cancer cells. Moreover, MAPK1 overexpression attenuated the effect of LINC00483 knockdown on gastric cancer development. LINC00483 could increase MAPK1 expression by competitively sponging miR-490-3p. miR-490-3p overexpression suppressed gastric cancer development, which was abated by introduction of LINC00483. |
mechanism |
- |
- |
- |
MAPK1 |
protein-coding |
32293550 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
LINC00483 positively regulated MAPK1 by sponging miR‑490‑3p in gastric cancer cells |
mechanism |
- |
- |
- |
MIR103A1 |
miRNA |
29754469 |
Cell proliferation assay; Cell colony formation assay;Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-103a-3p increases GC cell growth, and miR-103a-3p overexpression promotes the S-G2/M transition in vitro. |
target |
- |
- |
- |
MIR103A1 |
miRNA |
29754469 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-103a-3p directly regulates ATF7 expression in GC cells. |
target |
- |
- |
- |
MIR106B |
miRNA |
30907988 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-106b inhibitor could promote the apoptosis of gastric cancer cells |
mechanism |
- |
- |
- |
MIR106B |
miRNA |
30907988 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-106b targeted ALEX1 in gastric cancer cells |
mechanism |
- |
- |
- |
MIR106B |
miRNA |
29434197 |
Luciferase reporter assay; Immunoblotting |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-106b-5p targets p21 to regulate the cellular senescence in BRD4-inhibited cells. BRD4 regulates miR-106b-5p transcription via E2F for cellular senescence. |
target |
- |
- |
- |
MIR126 |
miRNA |
25027343 |
Cell proliferation assay; Cell invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-126 inhibited GC cells invasion but did not affect its proliferation in vitro. |
target |
- |
- |
- |
MIR126 |
miRNA |
28260063 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
the expression levels of miR-126 were significantly downregulated in the GC cell lines compared with the GES-1 cells |
target |
- |
- |
- |
MIR126 |
miRNA |
28260063 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM9 is a direct target post-transcriptionally regulated by miR-126 in GC cells. |
target |
- |
- |
- |
MIR1275 |
miRNA |
31357957 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expression of miR-1275 inhibited the metastasis and invasion of GC cells. |
prognosis |
< 0.001 |
- |
- |
MIR1275 |
miRNA |
31357957 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
JAZF1 is a direct target of miR-1275 in GC cells. |
prognosis |
< 0.001 |
- |
- |
MIR129-1 |
miRNA |
29879625 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-129-5p could target the 3′UTR of ADAM9 mRNA and regulated its protein expression |
prognosis |
< 0.05 |
- |
- |
MIR129-1 |
miRNA |
29879625 |
Cell proliferation assay; Invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-129-5p overexpression reduced cell proliferation, cell colony formation and cell invasion capacity |
prognosis |
< 0.05 |
- |
- |
MIR1296 |
miRNA |
30530570 |
Cell proliferation assay; Invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-1296-5p inhibited cell proliferation, migration, and invasion in SGC-7901 and MGC-803 cells. |
mechanism |
- |
- |
- |
MIR1296 |
miRNA |
30530570 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDK6 and EGFR as novel targets of miR-1296-5p by a luciferase activity assay |
mechanism |
- |
- |
- |
MIR1303 |
miRNA |
24647998 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cell proliferation rates were reduced, and cell invasion and migratory ability was significantly restricted in miR-1303 inhibitor-transfected groups. |
target |
- |
- |
- |
MIR1303 |
miRNA |
24647998 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-1303 could bind to the putative binding sites in CLDN18 mRNA 3'-UTR and visibly lower the expression of claudin-18. The introduction of claudin-18 without 3'-UTR restored the miR-1303 promoting migration function. |
target |
- |
- |
- |
MIR133A1 |
miRNA |
25152372 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDC42 is the direct target of miR-133a |
prognosis |
0.003 |
- |
- |
MIR133A1 |
miRNA |
25152372 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-133a supresses gastric cancer cell growth, migration and invasion. |
prognosis |
0.003 |
- |
- |
MIR135B |
miRNA |
32119960 |
Luciferase reporter assay; RIP |
cell line |
- |
- |
- |
- |
- |
No Reports |
PCAT18 and CLDN11 are the direct targets of miR-135b |
target |
- |
- |
- |
MIR135B |
miRNA |
32119960 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony forming assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Over-expression of miR-135b promotes proliferation, migration and invasion of AGS cells via CLDN11 inhibition. |
target |
- |
- |
- |
MIR136 |
miRNA |
30468468 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-136 was significantly downregulated in the gastric cancer cell lines as compared to the normal cell line |
target |
- |
- |
- |
MIR136 |
miRNA |
30468468 |
Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
transfection of AGS cells with miR-136 promoted apoptosis |
target |
- |
- |
- |
MIR137 |
miRNA |
26102366 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
The re-introduction of miR-137 into gastric cancer cells was able to inhibit cell proliferation, migration and invasion. |
mechanism |
- |
- |
- |
MIR137 |
miRNA |
26102366 |
Luciferase reporter assay; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-137 targets AKT2 in GC |
mechanism |
- |
- |
- |
MIR142 |
miRNA |
30178386 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
MiR-142-5p inhibited cancer cell migration and invasion both in vitro and in vivo. |
target/prognosis |
0.001 |
- |
- |
MIR142 |
miRNA |
30178386 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CYR61 is a novel target of miR‑142‑5p in GC cells |
target/prognosis |
0.001 |
- |
- |
MIR143 |
miRNA |
28404925 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-143-3p suppressed cell proliferation, induced apoptosis and inhibited cell migration and invasion. |
target |
- |
- |
- |
MIR143 |
miRNA |
28404925 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AKT2 is a direct target of miR-143-3p |
target |
- |
- |
- |
MIR145 |
miRNA |
28490034 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-145 target gene E2F3 was strongly expressed following CRNDE competitive molecular sponging of miR-145. |
mechanism |
- |
- |
- |
MIR148A |
miRNA |
27518872 |
Cell proliferation assay; Cell migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expression of miR-148a inhibited tumor cell proliferation and migration in vitro. More importantly, siRNA-induced knockdown of CCK-BR elicited similar anti-oncogenic effects (decreased proliferation and migration) as those induced by enforced miR-148a expression. |
target |
- |
- |
- |
MIR148A |
miRNA |
27518872 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cholecystokinin B receptor (CCK-BR) was a direct target of miR-148a |
target |
- |
- |
- |
MIR152 |
miRNA |
28427226 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Elevation of miR-152 enhanced T cells proliferation and effector cytokines production via inhibiting B7-H1/PD-1 pathway. |
target |
- |
- |
- |
MIR152 |
miRNA |
28427226 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-152 directly bind to B7-H1 3' untranslated region in gastric cancer cell and inhibited B7-H1 expression. |
target |
- |
- |
- |
MIR155 |
miRNA |
26955820 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Enforced expression of miR-155 impaired GC cell proliferation, promoted G1 phase arrest and induced apoptosis in vitro. In addition, we identified cyclin D1 as the direct target of miR-155, and knockdown of cyclin D1 partially phenocopied the role of miR-155 in GC cells. |
target |
- |
- |
- |
MIR155 |
miRNA |
26955820 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cyclin D1 is a direct target of miR‐155 in GC cells |
target |
- |
- |
- |
MIR15A |
miRNA |
26894855 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-15a suppressed gastric cancer invasion; miR-15a suppressed the proliferation of gastric cancer cells via downregulation of Bmi-1. |
mechanism |
- |
- |
- |
MIR15A |
miRNA |
26894855 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Bmi-1 is a direct target of miR-15a in gastric cancer cell lines. |
mechanism |
- |
- |
- |
MIR181A1 |
miRNA |
24531888 |
Cell proliferation assay; Invasion and migration assays; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-181a affects the proliferation and metastatic potential of gastric cancer cells. |
mechanism |
- |
- |
- |
MIR187 |
miRNA |
27864146 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-187 significantly increased migration, invasion, and proliferation, but inhibited apoptosis in GC cells |
target |
- |
- |
- |
MIR187 |
miRNA |
27864146 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CRMP1 was a direct downstream target of miR-187 in GC.The effects of miR-187 inhibitor on cell migration and cell apoptosis were reversed by CRMP1 downregulation |
target |
- |
- |
- |
MIR191 |
miRNA |
24603541 |
qRT-PCR |
cell line |
China |
- |
- |
Up |
- |
|
Examination of miR-191 and miR-425 expression in four GC cell lines (HGC-27,MGC-803, MKN-45 and SGC-7901) indicated an obvious upregulation of miR-191/425 in HGC-27, MGC-803, and SGC-7901 cell lines when compared to adjacent non-tumor tissues and five normal gastric tissues from healthy people |
mechanism |
- |
- |
- |
MIR1915 |
miRNA |
31036603 |
Cell proliferation assay,Cell apoptosis assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
It was found that the miR-1915-3p inhibited the growth of gastric cancer cells and promoted cell apoptosis. |
prognosis |
0.01 |
- |
- |
MIR1915 |
miRNA |
31036603 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-1915-3p directly inhibits Bcl-2 expression at post-transcriptional level through its 3'-UTR. |
prognosis |
0.01 |
- |
- |
MIR193A |
miRNA |
29848678 |
Cell proliferation assay; Cell colony formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expressions of miR-193a-5p and miR-193a-3p revealed that they both inhibited gastric cancer cell growth, but only miR-193a-3p significantly suppressed cell invasion ability. |
mechanism |
- |
- |
- |
MIR193A |
miRNA |
29848678 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ETS1 and CCND1 are direct target of miR-193a-3p |
mechanism |
- |
- |
- |
MIR193B |
miRNA |
27071318 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-193b can inhibit the proliferation, migration and invasion of HGC-27 and MGC-803 GC cells. |
mechanism |
- |
- |
- |
MIR194-1 |
miRNA |
27810403 |
Cell proliferation assay; Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miRNA-194 promoted cell proliferation and migration, while inhibition of miRNA-194 blocked these processes. |
target |
- |
- |
- |
MIR194-1 |
miRNA |
27810403 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SUFU is the functional target of miRNA-194 |
target |
- |
- |
- |
MIR198 |
miRNA |
30927924 |
Cell cytotoxicity assay; Clonogenic assay; Flow ytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-198 inhibited cell viability and induced apoptosis in SGC7901CDDP and BGC823CDDP cells. |
mechanism |
- |
- |
- |
MIR198 |
miRNA |
30927924 |
Luciferase reporter assay: RNA pull-down; FISH |
cell line |
- |
- |
- |
- |
- |
No Reports |
circAKT3 and miR-198 were colocalized in the cytoplasm; circAKT3 exerts its function by sponging miR-198. |
mechanism |
- |
- |
- |
MIR199A1 |
miRNA |
30193607 |
Cell proliferation assay; Cell migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Over-expression of miR-199 inhibited the proliferation and migration of GC cells. |
target |
- |
- |
- |
MIR199A1 |
miRNA |
30193607 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-199 directly targeted on the 3' untranslated region of TBL1XR1. |
target |
- |
- |
- |
MIR19A |
miRNA |
25914465 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-19a promoted the proliferation, migration and invasion. |
target |
- |
- |
- |
MIR19A |
miRNA |
25914465 |
Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpressing miR19a GC cells promoted phosphorylation of PI3KAKT, and the phosphorylation of PI3KAKT was blocked in the cells transfected with miR-19a mimic. |
target |
- |
- |
- |
MIR203A |
miRNA |
30837034 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-203 Suppressed the Invasion and EMT of GC Cells Through Inhibition of Annexin A4 |
target |
- |
- |
- |
MIR203A |
miRNA |
30837034 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-203 Directly Targets Annexin A4 in GC Cells |
target |
- |
- |
- |
MIR203A |
miRNA |
30837034 |
qRT-PCR; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
overexpression of miR-203 could inhibit EMT of GC cells |
target |
- |
- |
- |
MIR203A |
miRNA |
25373785 |
Cell proliferation assay; Invasion and migration assays; Clonal formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expression of miR-203 dramatically suppressed cell proliferation and invasion. We found that miR-203 strongly reduced the expression of CASK oncogene in GC cells. Similar to the restoring miR-203 expression, CASK down-regulation inhibited cell growth and invasion, whereas CASK over-expression rescued the suppressive effect of miR-203. These results can also be found in nude mice. In clinical specimens, CASK was over-expressed in tumors and H. pylori positive tissues and its mRNA levels were inversely correlated with miR-203 expression |
mechanism |
- |
- |
- |
MIR203A |
miRNA |
25373785 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CASK was a direct target of miR-203 in GC cells. |
mechanism |
- |
- |
- |
MIR204 |
miRNA |
23152059 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-204-mediated targeting of Bcl-2 expression pro_x005fmotes apoptosis of GC cells. |
prognosis |
0.017 |
- |
- |
MIR204 |
miRNA |
23152059 |
Cell migration assay; Cell colony formation assay; Cell apoptosis assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-204 overexpression affects cell migration, colony forming ability and chemoresistance. |
prognosis |
0.017 |
- |
- |
MIR208A |
miRNA |
29886152 |
Cell proliferation assay; Cell invasion assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expression of miR-208a by treatment with miR-208a mimic promoted cell proliferation and invasion abilities, but downregulation of miR-208a by treatment with miR-208a inhibitor had an opposite effects. |
target/prognosis |
< 0.05 |
- |
- |
MIR208A |
miRNA |
29886152 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SFRP1 is a direct target of MiR-208a in GC cells |
target/prognosis |
< 0.05 |
- |
- |
MIR208A |
miRNA |
29886152 |
Luciferase reporter assay; RIP |
cell line |
- |
- |
- |
- |
- |
No Reports |
MEG3 is a bona fide target for miR-208a in GC cells |
target/prognosis |
< 0.05 |
- |
- |
MIR208A |
miRNA |
27634902 |
Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-208a-3p suppresses apoptosis of gastric cancer cells by targeting PDCD4 |
target |
- |
- |
- |
MIR208A |
miRNA |
27634902 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
PDCD4 is a direct target of miR-208a-3p |
target |
- |
- |
- |
MIR21 |
miRNA |
30700111 |
Cell proliferation assay; Migration assay; Flow cytometer; Cell cycle assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Down-regulation of miR-21 markedly reduced gastric cancer cell proliferation and promoted cell apoptosis and repressed cell cycle progression; Silencing miR-21 dramatically blocked gastric cancer cell migration and movement. |
target |
- |
- |
- |
MIR217 |
miRNA |
30063010 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDH1 is a direct target of miR-217 |
mechanism |
- |
- |
- |
MIR217 |
miRNA |
30063010 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-217 overexpression contributes to increased GC cells proliferation |
mechanism |
- |
- |
- |
MIR27A |
miRNA |
27409164 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry; Apotosis assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-27a-3p, but not miR-27a-5p, markedly promoted gastric cancer cell proliferation in vitro. miR-27a-3p/BTG2 axis regulates cell cycle progression and apoptosis in gastric cancer cells |
target |
- |
- |
- |
MIR27A |
miRNA |
27409164 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BTG2 was a direct and functional target of miR-27a-3p in gastric cancer and miR-27a-3p inhibition obviously up-regulated the expression of BTG2. |
target |
- |
- |
- |
MIR29A |
miRNA |
25428377 |
Cell invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Introduction of miR-29a into GC cells resulted in decreased AKT2 expression and decreased the ability of cancer cells invasion, so did the siRNA-AKT2. |
target |
- |
- |
- |
MIR29A |
miRNA |
25428377 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AKT2 was the direct target of the miR-29a in GC cells. |
target |
- |
- |
- |
MIR29B1 |
miRNA |
25428377 |
Cell invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Introduction of miR-29b into GC cells resulted in decreased AKT2 expression and decreased the ability of cancer cells invasion, so did the siRNA-AKT2. |
target |
- |
- |
- |
MIR29B1 |
miRNA |
25428377 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AKT2 was the direct target of the miR-29b in GC cells. |
target |
- |
- |
- |
MIR29C |
miRNA |
25428377 |
Cell invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Introduction of miR-29c into GC cells resulted in decreased AKT2 expression and decreased the ability of cancer cells invasion, so did the siRNA-AKT2. |
target |
- |
- |
- |
MIR29C |
miRNA |
25428377 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AKT2 was the direct target of the miR-29c in GC cells. |
target |
- |
- |
- |
MIR302B |
miRNA |
28743112 |
Cell proliferation assay; Cell colony formation assay; Apoptosis assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Enforced expression of miR-302b suppressed cell proliferation and cell cycle G1-S transition and induced apoptosis. |
mechanism |
- |
- |
- |
MIR302B |
miRNA |
28743112 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
IGF-1R was found to be a direct target of miR-302b-3p, and silencing of IGF-1R resulted in the same biological effects as those induced by miR-302b-3p overexpression in gastric cancer cells. Both overexpression of miR-302b-3p and silencing of IGF-1R decreased AKT phosphorylation, which modulated AKT related cell cycle regulators (cyclin A2, cyclin D1, CDK2, and CDk6) and apoptotic protein Bax/Bcl-2. |
mechanism |
- |
- |
- |
MIR320A |
miRNA |
27086911 |
Clone formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-320a inhibits gastric cancer cell proliferation by suppressing activity in the FoxM1-P27KIP1 axis. |
mechanism |
- |
- |
- |
MIR320A |
miRNA |
27086911 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
FoxM1 is a direct target of miR-320a |
mechanism |
- |
- |
- |
MIR320A |
miRNA |
29152656 |
Colony formation assay; MTS assay; Viability assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR‑320a inhibits cell growth and enhances sensitivity of GC cells to cisplatin and suppresses tumor growth in vivo. |
target |
- |
- |
- |
MIR320A |
miRNA |
29152656 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR‑320a directly targets ADAM10 in GC cells. |
target |
- |
- |
- |
MIR331 |
miRNA |
31182928 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Transfection of miR-331-3p inhi- bitor promoted BGC-823 cells proliferation, invasion and migration; transfection of miR-331-3p mimic suppressed MGC-803 cells proliferation, invasion and migration. |
target |
- |
- |
- |
MIR331 |
miRNA |
31182928 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Binding interaction exists between miR-331-3p and TGFBR1, circCACTIN and miR-331-3p |
target |
- |
- |
- |
MIR331 |
miRNA |
31182928 |
qRT-PCR; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
Both TGFBR1 mRNA and protein expression were regulated by circCACTIN through miR-331-3p |
target |
- |
- |
- |
MIR335 |
miRNA |
21822301 |
Cell invasion assay; Tumor metastasis formation assay; MTT proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-335 suppresses gastric cancer invasion and metastasis in vitro, but has no significant effects on cell proliferation of gastric cancer |
target |
- |
- |
- |
MIR335 |
miRNA |
21822301 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SP1 and Bcl-w are direct targets of miR-335. miR-335 suppresses gastric cancer invasion and metastasis by targeting Bcl-w and SP1 |
target |
- |
- |
- |
MIR338 |
miRNA |
30308487 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-338-3p could suppress cell proliferation and induce cell apoptosis, suppresses metastasis |
target |
- |
- |
- |
MIR338 |
miRNA |
30308487 |
Bisulfite sequence |
cell line |
- |
- |
- |
- |
- |
No Reports |
hyper-methylation is the main cause of miR-338-3p depression |
target |
- |
- |
- |
MIR338 |
miRNA |
30308487 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Rab14 is a direct target of miR-338-3p; miR-338-3p suppresses metastasis by targeting the Hhat-MMP signaling pathway |
target |
- |
- |
- |
MIR338 |
miRNA |
26617808 |
Cell proliferation assay; Invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Enforced expression of miR-338-3p inhibited proliferation, migration and invasion of gastric cancer cells in vitro |
target |
- |
- |
- |
MIR338 |
miRNA |
26617808 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM17 is a direct target of miR-338-3 and prescued the miR-338-3p mediated inhibition of cell proliferation, migration and invasion |
target |
- |
- |
- |
MIR338 |
miRNA |
25945841 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-338-3p inhibited the migration and invasion of GC cells in vitro and inhibits the EMT process in GC cells. |
target |
- |
- |
- |
MIR338 |
miRNA |
25945841 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-338-3p directly targeted zinc finger E-box-binding protein 2 (ZEB2) and metastasis-associated in colon cancer-1 (MACC1). |
target |
- |
- |
- |
MIR340 |
miRNA |
28057912 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of miR-340 significantly reduced cell viability and proliferation, and induced cell apoptosis of GC cells |
target |
- |
- |
- |
MIR34A |
miRNA |
23264087 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-34a expression in gastric cancer cells was significantly reduced compared to the normal gastric epithelial cell line. |
mechanism |
- |
- |
- |
MIR34A |
miRNA |
23264087 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
In the overexpressing miR-34a in HGC-27 cells, cellular viability was significantly reduced, the proliferation index decreased significantly and cellular apoptosis was significantly increased, the number of cells passing through the transwell chamber was significantly reduced. |
mechanism |
- |
- |
- |
MIR34A |
miRNA |
24068565 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-34a expression was down-regulated in cisplatin-resistant cell lines |
mechanism |
- |
- |
- |
MIR34A |
miRNA |
24068565 |
Cell viability assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
The over-expression of miR- 34a could improve the sensitivity of gastric cancer cells to cisplatin-based chemotherapies |
mechanism |
- |
- |
- |
MIR381 |
miRNA |
28193228 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
MiR-381 decreased gastric cancer cell proliferation, migration and invasion in vitro. |
target/prognosis |
0.024 |
0.037 |
- |
MIR381 |
miRNA |
28193228 |
Luciferase reporter assay; Western blot; IHC |
cell line |
- |
- |
- |
- |
- |
No Reports |
TMEM16A was identified as a direct target of miR-381 and the expression of miR-381 was inversely correlated with TMEM16A expression in gastric cancer tissues |
target/prognosis |
0.024 |
0.037 |
- |
MIR421 |
miRNA |
25041019 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
The over-expression of miR-421 promoted gastric cancer cell growth and inhibited apoptosis of the BGC-823 gastric cancer cell line. |
mechanism |
- |
- |
- |
MIR448 |
miRNA |
26852749 |
Cell proliferation assay; Colony formation; Invasion assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-448 suppressed the GC cell proliferation, colony formation, and invasion |
mechanism |
- |
- |
- |
MIR448 |
miRNA |
26852749 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
ADAM10 was a direct target gene of miR-448 in GC cell |
mechanism |
- |
- |
- |
MIR454 |
miRNA |
30810117 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
STAT3 is the target gene of miR-454-3p. |
- |
- |
- |
- |
MIR490 |
miRNA |
32293550 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
LINC00483 could increase MAPK1 expression by competitively sponging miR-490-3p. miR-490-3p overexpression suppressed gastric cancer development, which was abated by introduction of LINC00483 |
mechanism |
- |
- |
- |
MIR490 |
miRNA |
32293550 |
Cell viability assay; Invasion and migration assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Over expression of miR-490-3p resulted in obvious reduction in viability, migration and invasion as well as increase in apoptosis of GC cells. |
mechanism |
- |
- |
- |
MIR494 |
miRNA |
29568970 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Treatment with cinobufacini suppressed proliferation and promoted apoptosis of gastric cancer cells.knockdown of miR-494 in cinobufacini-treated cells promoted cell proliferation and inhibited cell apoptosis. Inhibition of BAG-1 in cinobufacini-treated cells partially abrogated the effects of miR-494 inhibitor on cell proliferation and apoptosis. |
mechanism |
- |
- |
- |
MIR519D |
miRNA |
29510377 |
Cell proliferation assay; Invasion and migration assays; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-519d-3p inhibited MGC803 cell proliferation and invasion and delayed G1/S phase transition.miR-519d-3p/BCL6 axis inhibits cell proliferation, invasion, and cell cycle by regulating cyclin B1, E-cadherin, and MMP2 levels in GC cells. |
target |
- |
- |
- |
MIR519D |
miRNA |
29510377 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
BCL6 Is the Target of miR-519d-3p |
target |
- |
- |
- |
MIR5590 |
miRNA |
30029874 |
Cell proliferation assay; Cell colony formation assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-5590-3p regulates GC cell proliferation and colony formation by G1/S transition |
target |
- |
- |
- |
MIR5590 |
miRNA |
30029874 |
RIP and Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-5590-3p as a direct target of DDX5. |
target |
- |
- |
- |
MIR582 |
miRNA |
29228422 |
Cell proliferation assay; Cell colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpressed miR-582-5p could attenuate cell proliferation and viability capacities, as well as promoted cell apoptosis and cell cycle arrest at G0/G1 phase. |
target |
- |
- |
- |
MIR582 |
miRNA |
29228422 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
AKT3 was chosen as the target gene of miR-582-5p. Moreover, restoration of AKT3 could impair tumor suppression role of miR-582-5p on gastric cancer growth. |
target |
- |
- |
- |
MIR589 |
miRNA |
30012200 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Gain- and loss-of function experiments showed that miR-589 promoted cell migration, metastasis and invasion in vitro and lung metastasis in vivo. |
target |
- |
- |
- |
MIR589 |
miRNA |
30012200 |
Luciferase reporter assay; ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-589 directly targeted LIFR to activate PI3K/AKT/c-Jun signaling. c-Jun bound to the promoter region of miR-589 and activated its transcription. |
target |
- |
- |
- |
MIR613 |
miRNA |
28701053 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDK9 is a direct target of miR-613 in gastric cancer |
target |
- |
- |
- |
MIR613 |
miRNA |
28701053 |
Cell proliferation assay; Invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-613 suppressed cell proliferation and migration in gastric cancer |
target |
- |
- |
- |
MIR615 |
miRNA |
29501762 |
Cell proliferation assay; Flow cytometry; Cell migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-615-3p inhibits apoptosis and promotes proliferation and migration ability in SGC7901 cell line. Overexpression of CELF2 could reverse miR-615-3p's oncogenic functions stated before. |
prognosis |
< 0.05 |
- |
- |
MIR644A |
miRNA |
27983935 |
Cell proliferation assay; Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Restoring the expression of miR-644a could significantly suppress the migration and invasion of HGC-27 and SGC-7901 cells, which might be correlated to its suppressive effect on the EMT process. |
target |
- |
- |
- |
MIR644A |
miRNA |
27983935 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
CtBP1 is a putative target gene of miR-644a in GC cells |
target |
- |
- |
- |
MIR675 |
miRNA |
28848149 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
FADD is a potential target of miR-675; H19/miR-675 axis inhibited expression of FADD. FADD downregulation subsequently inhibited the caspase cleavage cascades including caspase 8 and caspase 3. |
target |
- |
- |
- |
MIR675 |
miRNA |
28848149 |
Cell proliferation assay; Colony formation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of H19 and miR-675 promoted cell proliferation and inhibited cell apoptosis, whereas knockdown of H19 and miR-675 inhibited these effects. |
target |
- |
- |
- |
MIR711 |
miRNA |
26735582 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-711 could suppress SGC-7901 cell growth in a time-dependent manner. |
target |
- |
- |
- |
MIR711 |
miRNA |
26735582 |
Flow cytometry; Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-711 was found to downregulate CDK4 expression |
target |
- |
- |
- |
MIR874 |
miRNA |
23800944 |
Cell proliferation assay; Invasion and migration assays; Flow Cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Functional analyses indicated that ectopic miR-874 expression suppressed the growth, migration, invasion and tumorigenicity of GC cells, whereas miR-874 knockdown promoted these phenotypes. Down-regulation of Bcl-2, MT1-MMP, MMP-2 and MMP-9 and upregulation of caspase-3 activity and Bax were involved in miR-874 inducing cell apoptosis, and inhibiting migration and invasion. |
mechanism |
- |
- |
- |
MIR874 |
miRNA |
23800944 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-874 directly interacts with a putative binding site of AQP3-3'UTR |
mechanism |
- |
- |
- |
MIR9-1 |
miRNA |
21225631 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
MiR-9 interacts with a putative binding site in the CDX2 3'-UTR |
mechanism |
- |
- |
- |
MIR9-1 |
miRNA |
21225631 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
Suppression of miR-9 and overexpression of CDX2 elicit the same phenomenon of cell cycle arrest |
mechanism |
- |
- |
- |
MIR9-1 |
miRNA |
23383271 |
Cell proliferation assay; Invasion and migration assays; Flow Cytometry; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-9 suppressed the in vitro proliferation of gastric cancer cells through targeting cyclin D1; miR-9 attenuated the in vitro migration and invasion of gastric cancer cells through targeting Ets1 |
mechanism |
- |
- |
- |
MIR9-1 |
miRNA |
23383271 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
miR-9 directly targeted cyclin D1 and Ets1 in gastric cancer cells |
mechanism |
- |
- |
- |
MIRLET7A1 |
miRNA |
23519840 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
Let-7a miRNA transfection significantly inhibited the migration and invasion in MNK-45 cells |
mechanism |
- |
- |
- |
MIRLET7B |
miRNA |
30237418 |
qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
let-7b-expression level of SGC7901/DDP cells was significantly lower than for its parental SGC7901 cells. |
target |
- |
- |
- |
MIRLET7B |
miRNA |
30237418 |
Cell proliferation assay; Flow cytometry; |
cell line |
- |
- |
- |
- |
- |
No Reports |
Upregulation of let-7b could reverse the DDP resistance of gastric cancer SGC7901/DDP cells by inducing cell viability inhibition and apoptosis when exposed to DDP treatment. |
target |
- |
- |
- |
MIRLET7B |
miRNA |
30237418 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
let-7b directly targets AURKB by binding to its 3'UTR region in DDP-resistant gastric cancer cells to DDP. |
target |
- |
- |
- |
MIRLET7B |
miRNA |
25288334 |
Cell proliferation assay; Invasion assay; Cell colony fomation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
suppressed the growth and invasive capacityof GC cells |
target/prognosis |
- |
0.001 |
- |
MIRLET7B |
miRNA |
25288334 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
let-7b/g inhibited AKT2 expression by directly binding to its 3'UTR, reduced p-AKT (S473) activation and suppressed expression of the downstream effector pS6. |
target/prognosis |
- |
0.001 |
- |
MIRLET7B |
miRNA |
25510669 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony formation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Ectopic expression of let-7b suppressed the growth, migration, invasion, and tumorigenicity of GC cells, whereas let-7b knockdown promoted these phenotypes. |
target |
- |
- |
- |
MIRLET7B |
miRNA |
25510669 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Cthrc1 was a direct target of let-7b. |
target |
- |
- |
- |
MIRLET7G |
miRNA |
25288334 |
Cell proliferation assay; Invasion assay; Cell colony fomation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
suppressed the growth and invasive capacityof GC cells |
target |
- |
0.051 |
- |
MIRLET7G |
miRNA |
25288334 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
let-7b/g inhibited AKT2 expression by directly binding to its 3'UTR, reduced p-AKT (S473) activation and suppressed expression of the downstream effector pS6. |
target |
- |
0.051 |
- |
NMRAL2P |
pseudogene/lncRNA |
32469171 |
Cell proliferation assay; Flow cytometry; Transwell assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
NMRAL2P overexpression induced a more malignant phenotype and significantly inhibited the expression of ACOT7. |
mechanism |
- |
- |
- |
NMRAL2P |
pseudogene/lncRNA |
32469171 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
NMRAL2P indirectly methylated ACOT7 by binding to DNMT3b, thereby suppressing ACOT7 expression. |
mechanism |
- |
- |
- |
NOTCH4 |
protein-coding |
25511451 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Notch4 activation promoted GC growth in vitro, while Notch4 inhibition using ICN4 siRNA had opposite effects. |
target |
- |
- |
- |
PCAT18 |
lncRNA |
32119960 |
Cell proliferation assay; Cell invasion and migration assays; Cell colony forming assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
PCAT18 down-expression promoted proliferation, migration and invasion of gastric cancer cells. |
target |
- |
- |
- |
PCAT18 |
lncRNA |
32119960 |
Luciferase reporter assay; RIP |
cell line |
- |
- |
- |
- |
- |
No Reports |
PCAT18 is the direct target of miR-135b |
target |
- |
- |
- |
PDCD4 |
protein-coding |
27634902 |
Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
MKN45 cells transfected with the PDCD4 siRNA showed suppression of cell apoptosis, whereas overexpression of PDCD4 significantly promoted cell apoptosis |
target |
- |
- |
- |
PDCD4 |
protein-coding |
27634902 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
PDCD4 is a direct target of miR-208a-3p |
target |
- |
- |
- |
PIK3R1 |
protein-coding |
30927924 |
Western blot |
cell line |
- |
- |
- |
- |
- |
No Reports |
CDDP-resistant GC cells showed obvious increases in the expression of PIK3R1 mRNA and protein levels. |
target |
- |
- |
- |
PIK3R1 |
protein-coding |
30927924 |
Luciferase reporter assay; Western blot; qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
PIK3R1 is a direct target of miR-198; miR-198 mimics significantly inhibited PIK3R1 mRNA and protein levels and that ectopic PIK3R1 expression abolished the influence caused by miR-198 overexpression. |
target |
- |
- |
- |
PKM |
protein-coding |
28588255 |
Cell proliferation assay; Cell colony formation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
knockdown of PKM2 can inhibit GC cell proliferation, G1-S phase transition,especially, attenuate GC cell migration |
target/prognosis |
0.006 |
- |
- |
PKM |
protein-coding |
28588255 |
Western blot; cell transduction |
cell line |
- |
- |
- |
- |
- |
No Reports |
PKM2 mediates cell migration and autophagy via the PI3K/Akt signaling pathway. |
target/prognosis |
0.006 |
- |
- |
POU2F1 |
protein-coding |
25678401 |
Luciferase reporter assay;ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
POU2F1 directly binds to the ECD gene promoter and induces ECD expression. |
- |
- |
- |
- |
POU2F1 |
protein-coding |
25678401 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
POU2F1 silencing blocked the migration, invasion, and EMT processes induced by ACK1 overexpression in gC cells |
- |
- |
- |
- |
RASSF1 |
protein-coding |
26735582 |
Cell proliferation assay; Invasion and migration assays; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
The expression of RASSF1A could suppress the viability, migration and invasion capacity of SGC-7901 cell in vitro. |
target |
- |
- |
- |
RASSF1 |
protein-coding |
26735582 |
miRNA microarray; qRT-PCR |
cell line |
- |
- |
- |
- |
- |
No Reports |
The expression of miR-711 was higher in the pcDNA3.1-RASSF1A-transfected SGC-7901 cells than in the pcDNA3.1-vector-transfected SGC-7901 cells. |
target |
- |
- |
- |
SFRP1 |
protein-coding |
29886152 |
Cell proliferation assay; Cell invasion assay; |
cell line |
- |
- |
- |
- |
- |
No Reports |
SFRP1 partially reverses the effects of miR-208a on proliferation and invasion in GC |
target |
- |
- |
- |
SFRP1 |
protein-coding |
29886152 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SFRP1 is a direct target of MiR-208a in GC cells |
target |
- |
- |
- |
SIRT1 |
protein-coding |
30250020 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
knockdown of SIRT1 promoted GC cell migration and invasion in vitro and metastasis in vivo. Forced expression of SIRT1 in GC cells had the opposite effects. SIRT1 inhibited the expression of ARHGAP5 by physically associating with transcription factor c-JUN and deacetylating and inhibiting the transcriptional activity of c-JUN. |
target |
- |
- |
- |
SIRT1 |
protein-coding |
30250020 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SIRT1 inhibits expression of ARHGAP5 by physically interacting with and deacetylating c-JUN |
target |
- |
- |
- |
SKP2 |
protein-coding |
27572672 |
Cell proliferation assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Defective regulation of Skp2 or the presence of Skp2 inhibitor contribute to decreased proliferation in human gastric cancer cell lines.Skp2 inhibitor inhibits the proliferation of gastric cancer cells in a dose‑dependent manner |
target |
- |
- |
- |
SNHG7 |
lncRNA |
29131253 |
Cell proliferation assay; Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
The in vitro experiments showed that after SNHG7 expression was interfered, the proliferation of gastric cancer cells was inhibited with an increase in apoptotic rate and arrest of cell cycle in G1/G0 phase. |
target |
- |
- |
- |
SNORD105B |
snoRNA |
29554660 |
Cell proliferation assay; Invasion and migration assay; Clonogenic assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Snord105b promotes the proliferation, migration,invasion and clonogenictiy in multiple GC cell lines. The oncoqenic activity of snord105b was also confirmed with in vivo data. Mechanistically, snord105b specifically bound to ALDOA and affected C-myc, which plays a key role in carcinogenesis and tumor development. |
target |
- |
- |
- |
SNORD105B |
snoRNA |
29554660 |
RIP assay; CHIRP-MS |
cell line |
- |
- |
- |
- |
- |
No Reports |
Snord105b is associated with the ALDOA protein |
target |
- |
- |
- |
SOX9 |
protein-coding |
30154451 |
Luciferase reporter assay; ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SOX9 directly binds to the COL10A1 promoter and activates its transcription. |
prognosis |
0 |
- |
- |
STAT3 |
protein-coding |
30810117 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
STAT3 is the target gene of miR-454-3p. |
mechanism |
- |
- |
- |
SUFU |
protein-coding |
27810403 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
SUFU is the functional target of miRNA-194 |
target |
- |
- |
- |
TET2 |
protein-coding |
31242038 |
Apoptosis assay; Migration assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
TET2 decreased gastric cancer cell survival and suppressed metastasis |
prognosis |
< 0.01 |
- |
- |
TGFBR1 |
protein-coding |
31182928 |
Cell proliferation assay; Invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
TGFBR1 played a vital role in GC cells proliferation, invasion, migration, and EMT, which was positively regulated by circCACTIN. |
mechanism |
- |
- |
- |
TGFBR1 |
protein-coding |
31182928 |
Luciferase reporter assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
Binding interaction exists between miR-331-3p and TGFBR1. |
mechanism |
- |
- |
- |
TMEM41A |
protein-coding |
30015937 |
Cell proliferation assay; Invasion and migration assays; Cell immunofluorescence for cytoskeleton stain and autophagy |
cell line |
- |
- |
- |
- |
- |
No Reports |
Knockdown of TMEM41A in vitro decreased the GC cell migration ability by regulating epithelial-to-mesenchymal transition and cell autophagy, via the upregulation of E-cadherin and downregulating N-cadherin expression in GC cells. |
target |
- |
- |
- |
TNK2 |
protein-coding |
25678401 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
ACK1 induces EMT, invasion, and metastasis |
target/prognosis |
< 0.001 |
- |
- |
TNK2 |
protein-coding |
25678401 |
Western blot; Luciferase reporter assay; IHC |
cell line |
- |
- |
- |
- |
- |
No Reports |
ACK1 up-regulates ECD expression by increasing the level of POU2F1. |
target/prognosis |
< 0.001 |
- |
- |
XRCC5 |
protein-coding |
30217218 |
Cell proliferation assay; Cell invasion and migration assays; |
cell line |
- |
- |
- |
- |
- |
No Reports |
knockdown of XRCC5 attenuated the cell clonogenicity, proliferation,invasion and migration. |
prognosis |
< 0.01 |
- |
- |
XRCC5 |
protein-coding |
30217218 |
Luciferase reporter assay;ChIP assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
XRCC5 was identified as a CLC-3 promoter-binding protein, and both CLC-3 and XRCC5 were prognostic factors of overall survival in GC patients. |
prognosis |
< 0.01 |
- |
- |
YBX1 |
protein-coding |
25959498 |
RNA pull-down assay |
cell line |
- |
- |
- |
- |
- |
No Reports |
lncRNA GAS5 interacts with the transcriptional activator YBX1. |
target |
- |
- |
- |
YBX1 |
protein-coding |
25959498 |
Flow cytometry |
cell line |
- |
- |
- |
- |
- |
No Reports |
YBX1 depletion reduces G1 phase arrest by decreasing p21 expression. |
target |
- |
- |
- |
ZNF143 |
protein-coding |
27449034 |
Cell invasion and migration assays |
cell line |
- |
- |
- |
- |
- |
No Reports |
ZNF143 knockdown inhibits the migration and invasion of gastric cancer cells, and overexpression contributes to the migration and invasion of GC cells. |
target |
- |
- |
- |
ZNF143 |
protein-coding |
27449034 |
Western blot; cell transfection |
cell line |
- |
- |
- |
- |
- |
No Reports |
Overexpression of ZNF143 re- duced the expression of epithelial cell marker (E-cadherin) and induced the expression mesenchymal cell marker (N-cadherin, Vimentin), related transcription factors (snail, slug), and upregulated the expression of phosphorylation AKT. |
target |
- |
- |
- |